[Federal Register Volume 78, Number 205 (Wednesday, October 23, 2013)]
[Notices]
[Pages 63223-63224]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-24782]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-N-2013-1041]
Fibromyalgia Public Meeting on Patient-Focused Drug Development;
Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public meeting; request for comments; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is correcting a
document that appeared in the Federal Register of September 23, 2013
(78 FR 58313). The document announced a public meeting entitled
``Fibromyalgia Public Meeting on Patient-Focused Drug Development'' and
opportunity for public comment. The document published with an
incorrect date for submission of electronic and written comments. This
document corrects that error.
FOR FURTHER INFORMATION CONTACT: Graham Thompson, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, rm. 1199, Silver Spring, MD 20993, 301-796-
5003, FAX: 301-847-8443, email: [email protected].
SUPPLEMENTARY INFORMATION: In FR Doc 2013-23019, appearing on page
58313
[[Page 63224]]
in the Federal Register of Monday, September 23, 2013, the following
corrections are made:
1. On page 58313, in the first column, in the ``Dates'' section,
the last sentence is corrected to read ``Submit electronic or written
comments by February 10, 2014.''
2. On page 58314, in the second column, in the fourth full
paragraph, the last sentence is corrected to read ``Comments may be
submitted until February 10, 2014.''
Dated: October 3, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-24782 Filed 10-22-13; 8:45 am]
BILLING CODE 4160-01-P